Fennec Pharmaceuticals Inc.

GOLDMAN SACHS GROUP INC FENC

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

43,589

Value ($000)

336

Weight

0.0%

2019 Q4 - 2025 Q4 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	336	0.0%	43,589	12/31/2025
2025 Q3	11/14/2025	248	0.0%	26,490	9/30/2025
2025 Q2	8/14/2025	132	0.0%	15,938	6/30/2025
2025 Q1	6/27/2025	263	0.0%	43,220	3/31/2025
2024 Q4	2/11/2025	450	0.0%	71,197	12/31/2024
2024 Q3	11/14/2024	269	0.0%	53,753	9/30/2024
2024 Q2	8/13/2024	123	0.0%	20,134	6/30/2024
2024 Q1	5/15/2024	479	0.0%	43,091	3/31/2024
2023 Q4	5/14/2024	348	0.0%	31,000	12/31/2023
2023 Q3	5/15/2024	130	0.0%	17,336	9/30/2023
2023 Q2	5/14/2024	272	0.0%	30,832	6/30/2023
2023 Q1	5/14/2024	173	0.0%	20,751	3/31/2023
2022 Q4	5/14/2024	201	0.0%	20,985	12/31/2022
2022 Q2	5/14/2024	56	0.0%	10,029	6/30/2022
2022 Q1	5/16/2022	73	0.0%	13,080	3/31/2022
2021 Q4	2/17/2022	59	0.0%	13,448	12/31/2021
2021 Q3	1/20/2022	127	0.0%	13,432	9/30/2021
2021 Q2	8/13/2021	98	0.0%	13,398	6/30/2021
2021 Q1	5/17/2021	131	0.0%	21,057	3/31/2021
2020 Q4	2/12/2021	184	0.0%	24,671	12/31/2020
2020 Q3	11/13/2020	150	0.0%	24,800	9/30/2020
2020 Q2	8/12/2020	255	0.0%	30,561	6/30/2020
2020 Q1	5/15/2020	84	0.0%	14,224	3/31/2020
2019 Q4	2/14/2020	92	0.0%	14,224	12/31/2019